Details for New Drug Application (NDA): 040253
✉ Email this page to a colleague
The generic ingredient in ETHOSUXIMIDE is ethosuximide. There is one drug master file entry for this compound. Eight suppliers are listed for this compound. Additional details are available on the ethosuximide profile page.
Summary for 040253
Tradename: | ETHOSUXIMIDE |
Applicant: | Pharm Assoc |
Ingredient: | ethosuximide |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 040253
Physiological Effect | Decreased Central Nervous System Disorganized Electrical Activity |
Medical Subject Heading (MeSH) Categories for 040253
Suppliers and Packaging for NDA: 040253
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ETHOSUXIMIDE | ethosuximide | SYRUP;ORAL | 040253 | ANDA | PAI Holdings, LLC | 0121-0670 | 0121-0670-16 | 473 mL in 1 BOTTLE (0121-0670-16) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SYRUP;ORAL | Strength | 250MG/5ML | ||||
Approval Date: | Nov 22, 2000 | TE: | AA | RLD: | No |
Complete Access Available with Subscription